These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9388038)

  • 1. Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium.
    Weyerbrock S; Schreieck J; Karch M; Overbeck M; Meisner H; Kemkes B; Schömig A; Schmitt C
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):571-5. PubMed ID: 9388038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium.
    Bosch RF; Milek IV; Popovic K; Mermi J; Mewis C; Kühlkamp V; Seipel L
    J Cardiovasc Pharmacol; 1999 May; 33(5):762-71. PubMed ID: 10226864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B; Iost N; Simon J; Varró A; Papp JG
    Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
    Zhang ZH; Follmer CH; Sarma JS; Chen F; Singh BN
    J Pharmacol Exp Ther; 1992 Oct; 263(1):40-8. PubMed ID: 1403801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies.
    Gjini V; Korth M; Schreieck J; Weyerbrock S; Schömig A; Schmitt C
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):314-20. PubMed ID: 8856489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle.
    Takanaka C; Sarma JS; Singh BN
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):290-8. PubMed ID: 1376799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on atrial repolarization of the interaction between K+ channel blockers and muscarinic receptor stimulation.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1095-104. PubMed ID: 7791080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes.
    Koidl B; Flaschberger P; Schaffer P; Pelzmann B; Bernhart E; Mächler H; Rigler B
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):226-32. PubMed ID: 8717164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,8-diazabicyclo--[3.2.1]-octane derivatives as analogues of ambasilide, a Class III antiarrhythmic agent.
    Villa S; Barlocco D; Cignarella G; Papp GJ; Baláti B; Takács J; Varró A; Borosy A; Keserû K; Mátyus P
    Eur J Med Chem; 2001 Jun; 36(6):495-506. PubMed ID: 11525840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes.
    Feng J; Wang Z; Li GR; Nattel S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):384-92. PubMed ID: 9103521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
    Wang J; Feng J; Nattel S
    Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes.
    Yue L; Feng JL; Wang Z; Nattel S
    Cardiovasc Res; 2000 Apr; 46(1):151-61. PubMed ID: 10727663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
    Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
    Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation.
    Stramba-Badiale M; Pessano P; Kirchengast M; Schwartz PJ
    Am Heart J; 1995 Mar; 129(3):549-56. PubMed ID: 7872187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiological modulation by NS-7, a novel neuroprotective drug, of guinea pig ventricular muscles.
    Satoh H
    Life Sci; 2003 Jan; 72(9):1039-48. PubMed ID: 12495782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
    Mehdirad AA; Carnes CA; Nelson SD
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ambasilide in isolated perfused guinea pig heart: use dependence.
    Kijtawornrat A; Hamlin RL; Hamlin DM
    Cardiovasc Toxicol; 2005; 5(1):53-62. PubMed ID: 15738585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
    Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.
    Lengyel C; Iost N; Virág L; Varró A; Lathrop DA; Papp JG
    Br J Pharmacol; 2001 Jan; 132(1):101-10. PubMed ID: 11156566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.